
Multi-tenant SaaS ICSR (Individual Case Safety Report) management application for sponsors and CROs that handles intake, triage, MedDRA/WHODrug coding, case processing, E2B(R3) submission, and partner exchange in a single Vault, on the same platform as Veeva Clinical, RIM, Quality, and Medical.
Veeva Safety (originally "Vault Safety" — Veeva has been progressively dropping the "Vault" prefix in marketing) is an adverse event and case management system. Veeva Systems launched Vault Safety as a generally available product in late 2019 with four early-adopter customers including Apellis Pharmaceuticals and Catalyst Clinical Research. Veeva's product page reports a "Mature" status with "51-100" customers.
The Veeva Safety Suite includes: Veeva Safety (ICSR case management — the subject of this profile); Veeva SafetyDocs (PV content management for PSMF, PVA, RMP, aggregate reports, signal investigations); Veeva Safety Workbench (OLAP-based advanced reporting/analytics); Veeva Safety Signal (signal detection and management); and Veeva AI for Safety (Case Intake Agent and Case Narrative Agent — announced GA April 2026).
Architecturally, Veeva Safety sits on the Vault Platform — Veeva's life-sciences-specific cloud, multi-tenant, with shared metadata model and Veeva Connections integration fabric. Customers running Veeva eTMF, CTMS, or RIM can wire Safety to those systems via vendor-published Connections rather than custom integrations. Veeva markets Safety as consolidating fragmented sponsor and CRO safety stacks onto one cloud database.
Veeva is a life-sciences-only vendor. Veeva positions Safety as appropriate for both emerging biotech (via "Veeva Basics" and the Safety for Emerging and Small Biotechs offering) and "top-20 global pharmaceutical" customers, with mid-cap pharma and CROs the most visible adopter segment to date.
Veeva Vault SaaS, multi-tenant — "All customers use the same core platform version, with data securely partitioned by organization." Three pre-validated releases per year. Vault Safety has never been on the Salesforce platform; it was built natively on Vault. Veeva AI Agents are hosted on Amazon Bedrock with LLMs from Anthropic and Amazon; underlying core Vault SaaS hosting is in SOC 2 Type II and ISO 27001 certified data centers (specific hyperscaler not named for the core). Browser-based access; no dedicated Safety mobile app. Vault Platform supports SAML 2.0 SSO (Okta, Azure AD, Ping commonly used by customers). Vault REST API is the primary integration mechanism; Vault webhooks supported; pre-built integrations via Veeva Connections to other Vault apps. Data residency: North America and EU regions; HDS certificate for French health-data hosting; China/Japan/APAC residency is undisclosed. Data standards: ICH E2B(R3) and E2B(R2) XML; MedDRA; WHODrug C3; EDQM; UCUM; IMDRF; ISO IDMP alignment; IDF (Japan); MFDS (Korea).
No list prices are published: Veeva does not typically publish pricing, and the Veeva Safety product page carries no pricing tiers. Subscription SaaS, priced per-tenant plus per-user / per-module. Third-party PV-database analysis reports Veeva Safety subscription pricing of $60K–$200K for emerging biotech / small-cap PV deployments. For top-20 pharma, deal sizes are reported as $1M+ annually when bundled with Veeva Safety Signal, SafetyDocs, and Safety Workbench, with implementation services on top. These figures are third-party reported, not vendor-confirmed. No free trial is advertised; demos and a "Live Demo Series" are publicly accessible. Veeva Vault contracts are typically multi-year (3-year is common) with annual subscription pricing. Vendor-delivered IQ/OQ artefacts are included with the subscription.
Veeva does not publish a standard implementation duration. Third-party analysis and partner case studies indicate: emerging biotech / single-product mid-cap — reported as 3-6 months; mid-cap pharma migration — reported as 6-12 months (consistent with the Daelight Solutions Argus → Vault migration); large pharma / top-20 — reported as 12-24 months, particularly when reconciling MedDRA versions, global partner gateways, and multi-product safety domain consolidation. Veeva Professional Services provides core implementation; partner system-integrator ecosystem includes Accenture, Cognizant, Deloitte, HCLTech, Infosys, Capgemini, PwC, TCS, Indegene, ZS (Everest Group's Veeva Services PEAK Matrix 2025). Specialist Veeva Safety implementation partners include Daelight Solutions and Pinnaxis. Migrations from Argus, ArisGlobal, Ennov are executed by Veeva Professional Services or SI partners with case-extract scripts; Daelight publicly described an "over 2 million cases and 11 million documents" migration. Common pitfalls: data migration scope creep from Argus (nested follow-ups, attached documents), MedDRA version reconciliation, partner gateway re-setup, validation effort underestimation, configuration sprawl on launch.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Users report Veeva Safety is "intuitive and easy to use" and that "having first-hand access to safety data is irreplaceable" (Hanssar Chacon, CRISPR Therapeutics). Customers also report case-processing-time reductions (Camurus: "at least 30 minutes per case"). The unified-cloud platform — same database for clinical, regulatory, quality, and safety — is repeatedly cited as a procurement driver, with Merck's Cory Gilbert noting "We'll connect clinical data directly into our safety database, reducing multiple data entry." CRO users (Biomapas) report eliminating dedicated server infrastructure. Three-times-yearly pre-validated releases reduce the burden of staying current with regulatory change.
Users and partners report the three-releases-per-year cadence is a standing CSV obligation that smaller PV teams underestimate. Vault Safety was described as "still a maturing solution" during a 2022-2024 large Argus-migration project. Capterra reviewers of the broader Vault report administrator complexity, customization-via-development rather than UI, and search efficacy dependent on disciplined metadata. Signal detection is delivered via a separately-licensed Veeva Safety Signal SKU. Safety-specific AI agents (Case Intake, Case Narrative) are announced for April 2026 GA.
Share your experience with Veeva Safety anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section